Deal Details

Accolade Completes $221.4 Million Follow-On Offering

Healthcare

Accolade follow-on offering

Summary

Accolade, Inc. (“Accolade” or “the Company”) (NASDAQ-GS:ACCD) recently completed an underwritten public offering of 5,750,000 shares of its common stock at a price to the public of $38.50 per share, including the underwriters’ option to purchase an additional 750,000 shares of common stock. The gross proceeds to Accolade from the offering are expected to be approximately $221.4 million before deducting the underwriting discounts and commissions. The Company intends to use the net proceeds from the offering for general corporate purposes, including working capital, operating expenses and capital expenditures.

Baird served as co-manager on this offering.

About

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Using a blend of cloud-based technologies, specialized support from Accolade Health Assistants® and Clinicians, and integrated data and programs across mobile, online and phone, Accolade navigates people through the healthcare system with trust, empathy and ease. Employers offer Accolade to employees and their families as the single place to turn for all health, healthcare, and benefits questions or concerns, increasing their engagement in benefits and connecting them to high-quality providers and care. By empowering members to make better decisions about their health, Accolade can support members in lowering the cost and complexity of healthcare while achieving consumer satisfaction ratings over 90 percent and a Net Promoter Score of 60. Accolade is co-headquartered in Seattle, Washington and Plymouth Meeting, Pennsylvania.

Healthcare

Accolade follow-on offering